Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer

BACKGROUND: Permanent prostate brachytherapy (PPB) is an effective treatment choice for low and intermediate risk prostate cancer (PCa). However, the impact of PPB on tumor immune status is still poorly understood. This study aimed to assess the immune status in PCa patients before and at different...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, E, Wang, Lin, Li, Chang-ying, Zhang, Chang-wen, Qu, Yan-chun, Liu, Ran-lu, Xu, Yong, Yang, Kuo, Zhang, Zhi-hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438076/
https://www.ncbi.nlm.nih.gov/pubmed/28546760
http://dx.doi.org/10.2147/OTT.S137491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438076/
https://www.ncbi.nlm.nih.gov/pubmed/28546760
http://dx.doi.org/10.2147/OTT.S137491

Ejemplares similares